MediciNova Statistics
Total Valuation
MediciNova has a market cap or net worth of $65.72 million. The enterprise value is $18.80 million.
| Market Cap | 65.72M |
| Enterprise Value | 18.80M |
Important Dates
The next estimated earnings date is Wednesday, August 7, 2024, after market close.
| Earnings Date | Aug 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MediciNova has 49.05 million shares outstanding.
| Shares Outstanding | 49.05M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 2.98% |
| Owned by Institutions (%) | 20.82% |
| Float | 42.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 65.72 |
| Forward PS | n/a |
| PB Ratio | 1.10 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 18.80 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 19.07, with a Debt / Equity ratio of 0.00.
| Current Ratio | 19.07 |
| Quick Ratio | n/a |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -13.30% and return on invested capital (ROIC) is -16.03%.
| Return on Equity (ROE) | -13.30% |
| Return on Assets (ROA) | -12.60% |
| Return on Capital (ROIC) | -16.03% |
| Revenue Per Employee | $76,923 |
| Profits Per Employee | -$646,810 |
| Employee Count | 13 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MediciNova has paid $3,047 in taxes.
| Income Tax | 3,047 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -46.40% in the last 52 weeks. The beta is 0.72, so MediciNova's price volatility has been lower than the market average.
| Beta (5Y) | 0.72 |
| 52-Week Price Change | -46.40% |
| 50-Day Moving Average | 1.39 |
| 200-Day Moving Average | 1.53 |
| Relative Strength Index (RSI) | 41.47 |
| Average Volume (20 Days) | 31,284 |
Short Selling Information
The latest short interest is 102,747, so 0.21% of the outstanding shares have been sold short.
| Short Interest | 102,747 |
| Short Previous Month | 110,732 |
| Short % of Shares Out | 0.21% |
| Short % of Float | 0.24% |
| Short Ratio (days to cover) | 2.91 |
Income Statement
In the last 12 months, MediciNova had revenue of $1.00 million and -$8.41 million in losses. Loss per share was -$0.17.
| Revenue | 1.00M |
| Gross Profit | 1.00M |
| Operating Income | -9.63M |
| Pretax Income | -8.41M |
| Net Income | -8.41M |
| EBITDA | -8.19M |
| EBIT | -8.41M |
| Loss Per Share | -$0.17 |
Balance Sheet
The company has $47.14 million in cash and $217,887 in debt, giving a net cash position of $46.92 million or $0.96 per share.
| Cash & Cash Equivalents | 47.14M |
| Total Debt | 217,887 |
| Net Cash | 46.92M |
| Net Cash Per Share | $0.96 |
| Equity (Book Value) | 59.83M |
| Book Value Per Share | 1.22 |
| Working Capital | 45.35M |
Cash Flow
In the last 12 months, operating cash flow was -$8.12 million and capital expenditures -$21,299, giving a free cash flow of -$8.14 million.
| Operating Cash Flow | -8.12M |
| Capital Expenditures | -21,299 |
| Free Cash Flow | -8.14M |
| FCF Per Share | -$0.17 |
Margins
Gross margin is 100.00%, with operating and profit margins of -962.57% and -840.85%.
| Gross Margin | 100.00% |
| Operating Margin | -962.57% |
| Pretax Margin | -840.55% |
| Profit Margin | -840.85% |
| EBITDA Margin | -818.96% |
| EBIT Margin | -840.55% |
| FCF Margin | -814.32% |
Dividends & Yields
MediciNova does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -12.79% |
| FCF Yield | -12.39% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on October 31, 2006. It was a reverse split with a ratio of 1:10.
| Last Split Date | Oct 31, 2006 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
MediciNova has an Altman Z-Score of 4 and a Piotroski F-Score of 1.
| Altman Z-Score | 4 |
| Piotroski F-Score | 1 |